Videos
Join the community
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 4. China’s healthcare defies Hang Seng slump with 0.9% gain 5. China's healthcare sector set for global breakoutResource Center
Partner Events
Event News
Medical Taiwan 2026 closes with $168.7m in business opportunities
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential